-
Karuna Therapeutics Inc. (KRTX) Surges After Trial Meets Primary Endpoint
-
Karuna Therapeutics to Present at the 2022 RBC Capital Markets Global Healthcare Conference
-
Karuna Therapeutics to Present at Upcoming Investor Conferences
-
Karuna Therapeutics Inc. (KRTX) PT Raised to $165 at RBC Capital, Sees Underappreciated De-Risking
-
UPDATE: RBC Capital Starts Karuna Therapeutics Inc. (KRTX) at Outperform

